Tekturna and Sensipar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tekturna (aliskiren hemifumarate) and Sensipar (cinacalcet hydrochloride). Common drug interactions include dizziness among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Tekturna and Sensipar. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Sensipar?

Sensipar has active ingredients of cinacalcet hydrochloride. It is often used in hyperparathyroidism secondary. eHealthMe is studying from 46,034 Sensipar users. Check the latest studies of Sensipar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

13 people who take Tekturna and Sensipar together, and have interactions are studied.

Tekturna and Sensipar drug interactions.

What are the common drug interactions of Tekturna and Sensipar, by gender? *:

female:

Dizziness
Fall
Nausea (feeling of having an urge to vomit)
Vomiting

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Nephrolithiasis (calculi in the kidneys)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Oedema peripheral (superficial swelling)
Gangrene (body tissue dies)
Multi-organ failure (multisystem organ failure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Renal injury (kidney injury)

What are the common drug interactions of Tekturna and Sensipar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Gastric ulcer (stomach ulcer)
Gastritis (inflammation of stomach)
Nausea (feeling of having an urge to vomit)
Vomiting

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Dizziness
Fall
Nausea (feeling of having an urge to vomit)
Vomiting
Renal injury (kidney injury)

60+:

Chronic kidney disease
Gangrene (body tissue dies)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Nephrolithiasis (calculi in the kidneys)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Oedema peripheral (superficial swelling)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 46.15%
Pain: 5 people, 38.46%
Infection: 4 people, 30.77%
Depression: 3 people, 23.08%
Diabetes: 3 people, 23.08%
Cardiac Disorder: 3 people, 23.08%
Indigestion: 3 people, 23.08%
Gout (uric acid crystals building up in the body): 3 people, 23.08%
Neuralgia (pain in one or more nerves): 3 people, 23.08%
Stress And Anxiety: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and Sensipar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously